ONL1204 Opthalmic solution clinical trials

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

This study is testing a new eye drop and an injection for a common cause of vision loss called Geographic Atrophy (GA), linked to Age-related Macular Degeneration (AMD). It aims to see how well these treatments work and if they are safe for people aged 55 and over.